首页> 美国卫生研究院文献>other >Synergistic Inhibition of HIV-1 Envelope-Mediated Membrane Fusion by Inhibitors Targeting the N- and C-Terminal Heptad Repeats of gp41
【2h】

Synergistic Inhibition of HIV-1 Envelope-Mediated Membrane Fusion by Inhibitors Targeting the N- and C-Terminal Heptad Repeats of gp41

机译:HIV-1包膜介导的膜融合的协同抑制作用的抑制剂靶向gp41的N和C端七肽重复序列。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The HIV-1 Envelope (Env) proteins that mediate membrane fusion represent a major target for the development of new AIDS therapies. Three classes of Env-mediated membrane fusion inhibitors have been described that specifically target the pre-hairpin intermediate conformation of gp41. Class 2 inhibitors bind to the C-terminal heptad repeat (C-HR) of gp41. The single example of a class 3 inhibitor targets the trimeric N-terminal heptad repeat (N-HR) of gp41 and has been postulated to sequestrate the N-HR of the pre-hairpin intermediate through the formation of fusion incompetent heterotrimers. In this paper we show that NCCG-gp41, a class 2 inhibitor, and N36Mut(e,g), a class 3 inhibitor, synergistically inhibit Env-mediated membrane fusion for several representative HIV-1 strains (X4 and R5) in both a cell fusion assay (with membrane-bound CD4) and an Env-pseudotyped virus neutralization assay. The mechanistic, as well as potential therapeutic, implications of these observation for HIV-Env mediated membrane fusion are discussed.
机译:调节膜融合的HIV-1信封(Env)蛋白是开发新的AIDS治疗方法的主要目标。已经描述了三类Env介导的膜融合抑制剂,它们专门针对gp41的发夹前中间体构象。 2类抑制剂与gp41的C端七肽重复序列(C-HR)结合。第3类抑制剂的单个实例靶向gp41的三聚体N末端七肽重复序列(N-HR),并已假定通过形成不适合的融合三聚体来隔离发夹前中间体的N-HR。在本文中,我们显示了2类抑制剂NCCG-gp41和3类抑制剂N36 Mut(e,g)对3种代表性HIV-1菌株协同抑制Env介导的膜融合。 (X4和R5)进行细胞融合测定(带有膜结合CD4)和Env-假型病毒中和测定。讨论了这些观察结果对HIV-Env介导的膜融合的机理以及潜在的治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号